Eradication ofHelicobacter pylorisignificantly reduced gastric damage in nonsteroidal anti-inflammatory drug-treated Mongolian gerbils
Author(s) -
Chun-Chao Chang,
Sheng-Hsuan Chen,
Gi Shih Lien,
Horng Yuan Lou,
Ching Ruey Hsieh,
Chia-Lang Fang,
Shiann Pan
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i1.104
Subject(s) - rofecoxib , medicine , gastroenterology , helicobacter pylori , stomach , gastritis , myeloperoxidase , prostaglandin , gerbil , cyclooxygenase , inflammation , chemistry , enzyme , biochemistry , ischemia
To examine the effect of eradication of Helicobacter pylori prior to usage of NSAIDs, by investigating gastric inflammatory activity, myeloperoxidase (MPO) activity, prostaglandin (PG) E2 synthesis in H pylori-infected, and H pylori-eradicated gerbils followed by administration of indomethacin and rofecoxib.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom